News
A breakthrough study presented at ESCMID Global 2025 highlights IL-6 as a highly accurate early biomarker for sepsis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback